Literature DB >> 29650563

Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD.

Signe Vedel-Krogh1,2, Børge G Nordestgaard1,2,3, Peter Lange2,4,5, Jørgen Vestbo6,7, Sune F Nielsen1,2.   

Abstract

Blood eosinophil count in chronic obstructive pulmonary disease (COPD) is associated with higher exacerbation rate and favourable response to corticosteroids; however, frequent exacerbations and use of inhaled corticosteroids could elevate pneumonia risk. We tested the hypothesis that high blood eosinophil counts are associated with high risk of pneumonia in individuals with severe COPD from the general population.We included 7180 individuals with COPD from the Copenhagen General Population Study, including 643 with forced expiratory volume in 1 s (FEV1) <50% predicted between 2003 and 2011. All primary discharge diagnoses of pneumonia during follow-up were recorded.Among individuals with COPD and FEV1 <50% pred, the multivariable adjusted incidence rate ratio was 2.17 (95% CI 1.31-3.58) for pneumonia comparing individuals with blood eosinophil counts ≥0.34×109 cells·L-1versus <0.34×109 cells·L-1 In individuals with clinical COPD, defined by recent exacerbation, ≥10 pack-years of smoking and FEV1 <70% pred, the corresponding risk was 4.52 (2.11-9.72). Risk of pneumonia did not differ by blood eosinophil count in individuals with COPD and FEV1 ≥50% pred.In individuals with COPD and FEV1 <50% pred, blood eosinophil count ≥0.34×109 cells·L-1 was associated with high risk of hospitalisation due to pneumonia.
Copyright ©ERS 2018.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29650563     DOI: 10.1183/13993003.00120-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Blood eosinophil level to predict chronic obstructive pulmonary disease clinical outcomes: not ready yet.

Authors:  Cheng-Sen Cai; Jun Wang
Journal:  Chin Med J (Engl)       Date:  2019-10-05       Impact factor: 2.628

2.  Association Between Blood Eosinophils and Mortality in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study.

Authors:  Jia Yang; Junchao Yang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-02-11

Review 3.  Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease.

Authors:  Pradeesh Sivapalan; András Bikov; Jens-Ulrik Jensen
Journal:  Diagnostics (Basel)       Date:  2021-02-03

Review 4.  The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Chih-Cheng Lai; Chao-Hsien Chen; Kuang-Hung Chen; Cheng-Yi Wang; Tsan-Ming Huang; Ya-Hui Wang; Hao-Chien Wang
Journal:  Life (Basel)       Date:  2022-01-25

Review 5.  Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts' review.

Authors:  Raja Dhar; Deepak Talwar; Sundeep Salvi; B V Muralimohan; Sagar Panchal; Saiprasad Patil; Sagar Bhagat; Nishtha Khatri; Hanmant Barkate
Journal:  ERJ Open Res       Date:  2022-03-28

6.  Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Tao Liu; Zi-Jian Xiang; Xiao-Meng Hou; Jing-Jing Chai; Yan-Li Yang; Xiao-Tong Zhang
Journal:  Ther Adv Chronic Dis       Date:  2021-07-07       Impact factor: 5.091

Review 7.  Clinical Approach to the Therapy of Asthma-COPD Overlap.

Authors:  Diego J Maselli; Megan Hardin; Stephanie A Christenson; Nicola A Hanania; Craig P Hersh; Sandra G Adams; Antonio Anzueto; Jay I Peters; MeiLan K Han; Fernando J Martinez
Journal:  Chest       Date:  2018-08-02       Impact factor: 10.262

8.  Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT.

Authors:  Mark T Dransfield; Courtney Crim; Gerard J Criner; Nicola C Day; David M G Halpin; MeiLan K Han; C Elaine Jones; Sally Kilbride; David LaFon; David A Lipson; David A Lomas; Neil Martin; Fernando J Martinez; Dave Singh; Robert A Wise; Peter Lange
Journal:  Ann Am Thorac Soc       Date:  2021-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.